Augmedix, Inc. provided revenue guidance for the year 2023. The company now expects approximately $44.5 million of revenue in 2023.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.75 USD | -2.69% |
|
-10.71% | -87.18% |
Jun. 04 | Augmedix, Inc. Reiterates Earnings Guidance for the Second Quarter and Full Year of 2024 | CI |
May. 29 | Augmedix Appoints Alex Stinard as Chief Clinical AI Officer | CI |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-87.18% | 36.73M | |
+17.98% | 72.14B | |
+8.63% | 17.66B | |
+19.70% | 14.64B | |
+16.31% | 13.15B | |
+11.68% | 9.8B | |
-23.29% | 6.4B | |
-10.54% | 5.59B | |
+3.66% | 5.29B | |
+9.59% | 4.89B |
- Stock Market
- Equities
- AUGX Stock
- News Augmedix, Inc.
- Augmedix, Inc. Provides Revenue Guidance for the Year 2023